Literature DB >> 24446346

Early stage of obesity potentiates nitric oxide reduction during the development of renal failure.

Ana María Gámez-Méndez1, Hilda Vargas-Robles, Mónica Arellano-Mendoza, Erika Cruz-Laguna, Amelia Rios, Bruno Escalante.   

Abstract

BACKGROUND: Obesity is a serious health problem associated with the pathogenesis of various metabolic diseases. Nitric Oxide (NO) plays an important role in kidney function and altered NO levels have been associated with the pathogenesis of obesity. Therefore, we aimed to study whether an early stage of obesity contributes with progression of renal failure through further NO impairment.
METHODS: Male C57BL/6 mice were fed with a high-fat diet (HFD) or a normal diet (ND) during 2 weeks. All mice underwent either sham surgery (sham) or 5/6 nephrectomy (Np). One group of HFD Np mice was treated with antioxidants plus L-arginine. Kidney damage parameters were assessed and eNOS metabolism was evaluated.
RESULTS: Mice on a HFD increased body weight, eNOS protein and mRNA expression, and radical oxygen species (ROS). Urine nitrites excretion, urine volume, and plasma BH4 were decreased. In HFD mice, 5/6 Np further increased BH2 and urine protein concentration, ROS levels, and eNOS mRNA expression. The decrease in BH4 plasma levels and urine nitrites excretion was accentuated. NO synthesis stimulation with the antioxidants + L-arginine treatment prevented all these changes.
CONCLUSIONS: The early changes in NO metabolism are associated with an early stage of obesity. This effect on NO potentiates kidney damage development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24446346     DOI: 10.1007/s40620-013-0029-9

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  34 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 3.  Obesity-associated hypertension: new insights into mechanisms.

Authors:  Kamal Rahmouni; Marcelo L G Correia; William G Haynes; Allyn L Mark
Journal:  Hypertension       Date:  2004-12-06       Impact factor: 10.190

4.  Oxidative stress in a rat model of obesity-induced hypertension.

Authors:  A D Dobrian; M J Davies; S D Schriver; T J Lauterio; R L Prewitt
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

5.  Vitamin C inhibits leptin secretion and some glucose/lipid metabolic pathways in primary rat adipocytes.

Authors:  D F Garcia-Diaz; J Campion; F I Milagro; N Boque; M J Moreno-Aliaga; J A Martinez
Journal:  J Mol Endocrinol       Date:  2010-04-16       Impact factor: 5.098

6.  Effect of cyclooxygenase-2 inhibition on renal function after renal ablation.

Authors:  P L Sanchez; L M Salgado; N R Ferreri; B Escalante
Journal:  Hypertension       Date:  1999-10       Impact factor: 10.190

Review 7.  Mechanisms of endothelial dysfunction in obesity.

Authors:  Angelo Avogaro; Saula Vigili de Kreutzenberg
Journal:  Clin Chim Acta       Date:  2005-10       Impact factor: 3.786

8.  Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Kozen Kinjo; Taku Inoue; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

9.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

Authors:  H O Steinberg; H Chaker; R Leaming; A Johnson; G Brechtel; A D Baron
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Leptin-induced endothelial dysfunction in obesity.

Authors:  Mykhaylo Korda; Ruslan Kubant; Stephen Patton; Tadeusz Malinski
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-08       Impact factor: 4.733

View more
  7 in total

1.  Pathological Hyperinsulinemia and Hyperglycemia in the Impaired Glucose Tolerance Stage Mediate Endothelial Dysfunction Through miR-21, PTEN/AKT/eNOS, and MARK/ET-1 Pathways.

Authors:  Ran Liu; Shilin Guan; Zhongai Gao; Jingyu Wang; Jie Xu; Zhaohu Hao; Yi Zhang; Shaohua Yang; Zhenhong Guo; Juhong Yang; Hailin Shao; Baocheng Chang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-23       Impact factor: 5.555

2.  Antioxidative diet supplementation reverses high-fat diet-induced increases of cardiovascular risk factors in mice.

Authors:  Hilda Vargas-Robles; Amelia Rios; Monica Arellano-Mendoza; Bruno A Escalante; Michael Schnoor
Journal:  Oxid Med Cell Longev       Date:  2015-04-01       Impact factor: 6.543

Review 3.  S-Nitrosylation: An Emerging Paradigm of Redox Signaling.

Authors:  Veani Fernando; Xunzhen Zheng; Yashna Walia; Vandana Sharma; Joshua Letson; Saori Furuta
Journal:  Antioxidants (Basel)       Date:  2019-09-17

Review 4.  S-Nitrosylation in Tumor Microenvironment.

Authors:  Vandana Sharma; Veani Fernando; Joshua Letson; Yashna Walia; Xunzhen Zheng; Daniel Fackelman; Saori Furuta
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

5.  Loss of Nitric Oxide Induces Fibrogenic Response in Organotypic 3D Co-Culture of Mammary Epithelia and Fibroblasts-An Indicator for Breast Carcinogenesis.

Authors:  Gang Ren; Xunzhen Zheng; Vandana Sharma; Joshua Letson; Andrea L Nestor-Kalinoski; Saori Furuta
Journal:  Cancers (Basel)       Date:  2021-06-05       Impact factor: 6.639

6.  Oxidative Stress-Dependent Coronary Endothelial Dysfunction in Obese Mice.

Authors:  Ana María Gamez-Mendez; Hilda Vargas-Robles; Amelia Ríos; Bruno Escalante
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

7.  Effects of astrogaloside on the inflammation and immunity of renal failure patients receiving maintenance dialysis.

Authors:  Renlian Sun; Haiwei Ren; Jianxin Wei
Journal:  Exp Ther Med       Date:  2018-01-05       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.